Axillary dissection compared to sentinel node biopsy for the treatment of pathologically node-negative breast cancer: a meta-analysis of four randomized trials with long-term follow up
Authors:
Open Access
- 2 October 2012
- journal article
- review article
- Published by Frontiers Media SA in Oncology Reviews
- Vol. 6 (2) , e20
Abstract
Sentinel lymph node biopsy is now accepted as the initial approach for women with early stage breast cancer with clinically node-negative disease. We performed a pooled analysis of trials comparing axillary lymph node dissection to sentinel lymph node biopsy in patients with early stage breast cancer and pathologically negative sentinel lymph node analysis. A systematic MEDLINE review identified four randomized trials of axillary dissection versus sentinel lymph node biopsy in lymph node-negative early stage breast cancer patients. A meta-analysis was performed for survival and relapse. The combined analyses of these four trials found no significant difference in overall survival (relative risk [RR] 1.15; P=0.16; 95% CI: 0.95-1.39), breast cancer-specific (RR 1.03; P=0.85; 95% CI: 0.75- 1.43) and disease-free survival (RR 1.07; P=0.3; 95% CI: 0.94-1.21), distant metastases (RR 1; P=0.98; 95% CI: 0.76-1.32), and ipsilateral breast recurrence (RR 1.64; P=0.34; 95% CI: 0.60-4.47) associated with sentinel lymph node biopsy. In particular, a similar rate of nodal recurrences was seen after sentinel lymph node biopsy (RR 1.74; P=0.13; 95% CI: 0.86- 3.53). Axillary dissection does not confer a survival benefit nor prevent further nodal relapses in the setting of early stage, pathologically lymph node-negative breast cancer.Keywords
This publication has 20 references indexed in Scilit:
- Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trialThe Lancet Oncology, 2010
- Sentinel Lymph Node Biopsy in Breast CancerAnnals of Surgery, 2010
- Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patientsCancer, 2009
- Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trialAnnals of Oncology, 2009
- Axillary dissection in breast-conserving surgery for stage i and ii breast cancer: a national cancer data base study of patterns of omission and implications for survival11No competing interests declared.Journal of the American College of Surgeons, 1999
- The Impact of Prophylactic Axillary Node Dissection on Breast Cancer Survival?A Bayesian Meta-AnalysisAnnals of Surgical Oncology, 1999
- Identification of women with T1-T2 breast cancer at low risk of positive axillary nodesJournal of Surgical Oncology, 1997
- The value of axillary dissection in T1a breast cancerThe American Journal of Surgery, 1996
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Ten-Year Results of a Randomized Clinical Trial Comparing Radical Mastectomy and Total Mastectomy with or without RadiationNew England Journal of Medicine, 1985